Pharmacy alerts
-
Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablet.
-
New contraindication for domperidone in patients with phaeochromocytoma
Drugs Safety Update: Domperidone, new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension.
-
Xaggitin XL Prolonged-release tablets (methylphenidate)
Class 4 medicines defect notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release tablets.
-
Botulinum toxin type A products: updated warnings
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update regarding the risk of iatrogenic botulism.
-
ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators recall
Class 2 medicines recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator.
-
Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP
Class 2 medicines recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP.